CareDx, Inc. (CDNA) stock
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3036% above fair value
$79.81−1.36 (-1.68%)
Close on Nov 12, 2026Market cap $4.19BP/E 33.4Yield –
CareDx cash
Cash and short-term investments held at the end of each period.
CareDx's cash was $250.48M at Sep 30, 2026. For fiscal 2025 it was $177.21M, down 32.2% from the year before. Over ten years it grew 19.4% a year on average. The highest annual figure on record is $348.70M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $177.21M | -32.2% |
| FY2024 | Dec 31, 2024 | $261.24M | +11.0% |
| FY2023 | Dec 31, 2023 | $235.40M | -19.7% |
| FY2022 | Dec 31, 2022 | $293.10M | -15.9% |
| FY2021 | Dec 31, 2021 | $348.70M | +55.2% |
| FY2020 | Dec 31, 2020 | $224.70M | +484.0% |
| FY2019 | Dec 31, 2019 | $38.48M | -40.6% |
| FY2018 | Dec 31, 2018 | $64.81M | +144.8% |
| FY2017 | Dec 31, 2017 | $26.47M | +52.1% |
| FY2016 | Dec 31, 2016 | $17.40M | -42.1% |
| FY2015 | Dec 31, 2015 | $30.04M | -17.6% |
| FY2014 | Dec 31, 2014 | $36.43M | +610.4% |
| FY2013 | Dec 31, 2013 | $5.13M | -12.0% |
| FY2012 | Dec 31, 2012 | $5.83M | +147.3% |
| FY2011 | Dec 31, 2011 | $2.36M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $250.48M | +29.0% |
| Q2 FY2026 | Jun 30, 2026 | $373.64M | +100.6% |
| Q1 FY2026 | Mar 31, 2026 | $187.18M | -18.9% |
| Q4 FY2025 | Dec 31, 2025 | $177.21M | -32.2% |
| Q3 FY2025 | Sep 30, 2025 | $194.22M | -19.4% |
| Q2 FY2025 | Jun 30, 2025 | $186.26M | -18.6% |
| Q1 FY2025 | Mar 31, 2025 | $230.92M | +7.0% |
| Q4 FY2024 | Dec 31, 2024 | $261.24M | +11.0% |
| Q3 FY2024 | Sep 30, 2024 | $240.90M | -10.2% |
| Q2 FY2024 | Jun 30, 2024 | $228.90M | -19.0% |
| Q1 FY2024 | Mar 31, 2024 | $215.90M | -24.5% |
| Q4 FY2023 | Dec 31, 2023 | $235.40M | -19.7% |
| Q3 FY2023 | Sep 30, 2023 | $268.20M | -7.9% |
| Q2 FY2023 | Jun 30, 2023 | $282.70M | -7.7% |
| Q1 FY2023 | Mar 31, 2023 | $285.90M | -10.4% |
| Q4 FY2022 | Dec 31, 2022 | $293.10M | -15.9% |
| Q3 FY2022 | Sep 30, 2022 | $291.30M | -19.8% |
| Q2 FY2022 | Jun 30, 2022 | $306.20M | -17.2% |
| Q1 FY2022 | Mar 31, 2022 | $319.20M | -14.7% |
| Q4 FY2021 | Dec 31, 2021 | $348.70M | +55.2% |
| Q3 FY2021 | Sep 30, 2021 | $363.30M | +69.9% |
| Q2 FY2021 | Jun 30, 2021 | $369.90M | +75.0% |
| Q1 FY2021 | Mar 31, 2021 | $374.30M | +1062.7% |
| Q4 FY2020 | Dec 31, 2020 | $224.70M | +484.0% |
| Q3 FY2020 | Sep 30, 2020 | $213.80M | +419.2% |
| Q2 FY2020 | Jun 30, 2020 | $211.41M | +383.5% |
| Q1 FY2020 | Mar 31, 2020 | $32.19M | -44.1% |
| Q4 FY2019 | Dec 31, 2019 | $38.48M | -40.6% |
| Q3 FY2019 | Sep 30, 2019 | $41.18M | +56.0% |
| Q2 FY2019 | Jun 30, 2019 | $43.72M | +166.2% |
| Q1 FY2019 | Mar 31, 2019 | $57.62M | +204.9% |
| Q4 FY2018 | Dec 31, 2018 | $64.81M | +144.8% |
| Q3 FY2018 | Sep 30, 2018 | $26.39M | +70.0% |
| Q2 FY2018 | Jun 30, 2018 | $16.42M | -12.0% |
| Q1 FY2018 | Mar 31, 2018 | $18.90M | -13.1% |
| Q4 FY2017 | Dec 31, 2017 | $26.47M | +52.1% |
| Q3 FY2017 | Sep 30, 2017 | $15.53M | – |
| Q2 FY2017 | Jun 30, 2017 | $18.66M | – |
| Q1 FY2017 | Mar 31, 2017 | $21.74M | – |
| Q4 FY2016 | Dec 31, 2016 | $17.40M | – |
See a number that looks wrong?